Sebastian Polak
About
In The Last Decade
Sebastian Polak
126 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 143
- Molecular Biology 503
- Cardiology and Cardiovascular Medicine 497
- Pharmaceutical Science 364
- Pharmacology 233
- Computational Theory and Mathematics 196
Countries citing papers authored by Sebastian Polak
This map shows the geographic impact of Sebastian Polak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Polak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Polak more than expected).
Fields of papers citing papers by Sebastian Polak
This network shows the impact of papers produced by Sebastian Polak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Polak. The network helps show where Sebastian Polak may publish in the future.
Co-authorship network of co-authors of Sebastian Polak
This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Polak. A scholar is included among the top collaborators of Sebastian Polak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Polak. Sebastian Polak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 5 | |
| 10 | 8 | |
| 11 | 6 | |
| 12 | 13 | |
| 13 | 6 | |
| 14 | ToxComp ∔ In vitro-in vivo extrapolation system for drug proarrhythmic potency assessment | 3 |
| 15 | Modeling and simulation approach for assessing proarrhythmic potency of the non-cardiological drugs | 1 |
| 16 | In silico prediction of the drug overdose consequences at the heart electrophysiology level | 1 |
| 17 | E-learning in pharmaceutical continuing education in Poland | 2 |
| 18 | Randomforest based assessment of the hERG channel inhibition potential for the early drug cardiotoxicity testing | 3 |
| 19 | E-learning with use of virtual patient in pharmacy education | 3 |
| 20 | From random utility to random expected utility: theory and application to departure time choice | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.